167 related articles for article (PubMed ID: 22159472)
1. Regulatory T-cell-mediated inhibition of antitumor immune responses is associated with clinical outcome in patients with liver metastasis from colorectal cancer.
Brudvik KW; Henjum K; Aandahl EM; Bjørnbeth BA; Taskén K
Cancer Immunol Immunother; 2012 Jul; 61(7):1045-53. PubMed ID: 22159472
[TBL] [Abstract][Full Text] [Related]
2. Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancer.
Betts G; Jones E; Junaid S; El-Shanawany T; Scurr M; Mizen P; Kumar M; Jones S; Rees B; Williams G; Gallimore A; Godkin A
Gut; 2012 Aug; 61(8):1163-71. PubMed ID: 22207629
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner.
Yaqub S; Henjum K; Mahic M; Jahnsen FL; Aandahl EM; Bjørnbeth BA; Taskén K
Cancer Immunol Immunother; 2008 Jun; 57(6):813-21. PubMed ID: 17962941
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.
Katz SC; Bamboat ZM; Maker AV; Shia J; Pillarisetty VG; Yopp AC; Hedvat CV; Gonen M; Jarnagin WR; Fong Y; D'Angelica MI; DeMatteo RP
Ann Surg Oncol; 2013 Mar; 20(3):946-55. PubMed ID: 23010736
[TBL] [Abstract][Full Text] [Related]
5. Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer.
Pedroza-Gonzalez A; Verhoef C; Ijzermans JN; Peppelenbosch MP; Kwekkeboom J; Verheij J; Janssen HL; Sprengers D
Hepatology; 2013 Jan; 57(1):183-94. PubMed ID: 22911397
[TBL] [Abstract][Full Text] [Related]
6. Low infiltration of peritumoral regulatory T cells predicts worse outcome following resection of colorectal liver metastases.
Nakagawa K; Tanaka K; Homma Y; Nojiri K; Kumamoto T; Takeda K; Endo I
Ann Surg Oncol; 2015 Jan; 22(1):180-6. PubMed ID: 25120248
[TBL] [Abstract][Full Text] [Related]
7. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
8. CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.
Clarke SL; Betts GJ; Plant A; Wright KL; El-Shanawany TM; Harrop R; Torkington J; Rees BI; Williams GT; Gallimore AM; Godkin AJ
PLoS One; 2006 Dec; 1(1):e129. PubMed ID: 17205133
[TBL] [Abstract][Full Text] [Related]
9. Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA
Zhang C; Wang Z; Yang Z; Wang M; Li S; Li Y; Zhang R; Xiong Z; Wei Z; Shen J; Luo Y; Zhang Q; Liu L; Qin H; Liu W; Wu F; Chen W; Pan F; Zhang X; Bie P; Liang H; Pecher G; Qian C
Mol Ther; 2017 May; 25(5):1248-1258. PubMed ID: 28366766
[TBL] [Abstract][Full Text] [Related]
10. Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.
Abd Al Samid M; Chaudhary B; Khaled YS; Ammori BJ; Elkord E
Oncotarget; 2016 Mar; 7(12):14083-94. PubMed ID: 26885615
[TBL] [Abstract][Full Text] [Related]
11. Role for the cAMP-protein kinase A signaling pathway in suppression of antitumor immune responses by regulatory T cells.
Yaqub S; Taskén K
Crit Rev Oncog; 2008; 14(1):57-77. PubMed ID: 19105570
[TBL] [Abstract][Full Text] [Related]
12. Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells.
Mandapathil M; Szczepanski MJ; Szajnik M; Ren J; Jackson EK; Johnson JT; Gorelik E; Lang S; Whiteside TL
J Biol Chem; 2010 Sep; 285(36):27571-80. PubMed ID: 20558731
[TBL] [Abstract][Full Text] [Related]
13. CD4
Pan Y; Wang H; An F; Wu F; Tao Q; Li Y; Ruan Y; Zhai Z
Int Immunopharmacol; 2021 Jul; 96():107742. PubMed ID: 33984717
[TBL] [Abstract][Full Text] [Related]
14. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
[TBL] [Abstract][Full Text] [Related]
15. Depleted polymorphonuclear leukocytes in human metastatic liver reflect an altered immune microenvironment associated with recurrent metastasis.
Hand F; Harmon C; Elliott LA; Caiazza F; Lavelle A; Maguire D; Hoti E; Nolan N; Geoghegan JG; Ryan EJ; O'Farrelly C
Cancer Immunol Immunother; 2018 Jul; 67(7):1041-1052. PubMed ID: 29572702
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer.
Waniczek D; Lorenc Z; Śnietura M; Wesecki M; Kopec A; Muc-Wierzgoń M
Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):445-454. PubMed ID: 28343267
[TBL] [Abstract][Full Text] [Related]
17. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).
Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K
Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244
[TBL] [Abstract][Full Text] [Related]
18. Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and
Hui Z; Zhang J; Zheng Y; Yang L; Yu W; An Y; Wei F; Ren X
Front Immunol; 2021; 12():619932. PubMed ID: 33868236
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.
Yuan XL; Chen L; Li MX; Dong P; Xue J; Wang J; Zhang TT; Wang XA; Zhang FM; Ge HL; Shen LS; Xu D
Clin Immunol; 2010 Mar; 134(3):277-88. PubMed ID: 19900843
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharides increase the risk of colorectal cancer recurrence and metastasis due to the induction of neutrophil extracellular traps after curative resection.
Wang WW; Wu L; Lu W; Chen W; Yan W; Qi C; Xuan S; Shang A
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2609-2619. PubMed ID: 34115241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
